NOV 17, 202662 MINS READ
Croscarmellose Sodium is synthesized by internal cross-linking of sodium carboxymethylcellulose through ester bond formation between carboxyl groups on adjacent cellulose chains 1. This cross-linking is typically achieved by lowering the pH during manufacture and applying heat, which promotes intramolecular and intermolecular esterification 16. The resulting three-dimensional network structure is characterized by a degree of substitution (DS) typically ranging from 0.60 to 0.85 for pharmaceutical-grade material 9. The cross-linking density is a critical parameter: excessive cross-linking reduces swelling capacity, while insufficient cross-linking leads to gel formation and loss of disintegrant functionality 1.
The fibrous morphology of Croscarmellose Sodium is evident in its particle size distribution. Commercial grades exhibit a median particle size (D50) ranging from 5 µm to 36 µm, with a volume mean diameter (D[4,3]) of 40 µm or less and a specific surface area typically ≥0.3 m²/g 1. Fine particle variants (D50 = 5–25 µm) offer enhanced surface area for water contact, while coarser grades (D50 ≥56 µm) are preferred at higher concentrations (≥4% w/w) to maintain acceptable disintegration times under compaction forces 7. Approximately 90% of particles are ≤44.5 µm, ensuring uniform distribution within tablet matrices 16.
The cross-linked structure imparts water insolubility while preserving hydrophilicity, a dual characteristic essential for the swelling mechanism 1. Unlike linear sodium carboxymethylcellulose, which dissolves to form viscous solutions, Croscarmellose Sodium particles absorb water many times their weight—often exceeding 20% by weight of the applied composition—without losing structural integrity 16. This behavior is attributed to the elastic deformation capacity of the cross-linked network, which expands upon hydration but does not dissolve 8.
The preparation of pharmaceutical-grade Croscarmellose Sodium involves controlled self-cross-linking of sodium carboxymethylcellulose (DS 0.60–0.85) in aqueous organic solvent systems under acidic catalysis 9. A representative synthesis protocol includes:
Alternative methods employ propylene glycol as a cross-linking agent under acidic conditions (pH 1.0–3.0), which offers milder reaction conditions and easier control of cross-linking degree 4. The choice of cross-linking agent and reaction parameters directly influences the final swelling capacity, particle size distribution, and disintegration performance 4.
Quality control during synthesis is critical to meet pharmacopeial standards (e.g., Chinese Pharmacopoeia 2010 edition, USP/NF). Key specifications include degree of substitution (0.60–0.85), loss on drying (≤10%), pH (5.0–7.0 for 1% aqueous dispersion), and heavy metals (≤20 ppm) 9. The cross-linking degree must be optimized to balance swelling capacity with mechanical stability: under-cross-linked material exhibits excessive gel formation, while over-cross-linked material shows reduced water uptake 9.
The disintegration action of Croscarmellose Sodium originates from a synergistic combination of wicking, swelling, and deformation recovery due to its fibrous, cross-linked structure 1. This multi-modal mechanism distinguishes it from other superdisintegrants such as crospovidone (which acts primarily by swelling) and sodium starch glycolate (which swells but may gel at high concentrations) 1.
The fibrous morphology of Croscarmellose Sodium creates an extensive network of capillary channels within and between particles 8. Upon contact with aqueous media, water is rapidly drawn into these channels by capillary forces, penetrating the tablet matrix and facilitating initial disintegration 1. The specific surface area (≥0.3 m²/g) and particle size distribution are critical determinants of wicking efficiency: finer particles (D50 = 5–25 µm) provide greater surface area for water contact, accelerating initial wetting 1. However, excessively fine particles may impede water penetration due to increased packing density and reduced interparticulate porosity 7.
Following wicking, water molecules penetrate the cross-linked cellulose network and hydrate the carboxymethyl groups (–CH₂COO⁻Na⁺), causing the polymer chains to extend and the particle volume to increase 1. The cross-links prevent dissolution but allow elastic expansion: individual particles can absorb water up to several times their dry weight without forming a paste or gum 16. This volumetric expansion generates internal stress within the tablet, disrupting interparticle bonds and promoting disintegration 1.
The extent of swelling is governed by the cross-link density and the degree of substitution. Higher DS values (0.80–0.85) provide more hydrophilic carboxymethyl groups, enhancing water uptake, but excessive substitution may reduce cross-linking efficiency 9. Conversely, higher cross-link density restricts chain mobility and limits swelling 1. Optimal pharmaceutical grades balance these parameters to achieve rapid, reproducible disintegration 9.
The fibrous, cross-linked structure of Croscarmellose Sodium imparts elastic properties that contribute to disintegration through deformation recovery 1. During tablet compression, particles are deformed and compacted; upon hydration, the absorbed water plasticizes the polymer network, allowing partial recovery of the original particle shape 8. This elastic rebound generates additional mechanical stress within the tablet matrix, further accelerating disintegration 1. The magnitude of deformation recovery depends on the compaction force, particle size, and cross-link density: coarser particles (D50 ≥56 µm) exhibit greater elastic recovery at high compaction forces (≥10 kN), making them suitable for high-dose or high-compression formulations 7.
Experimental studies demonstrate that tablets containing 0.5% Croscarmellose Sodium (D50 = 34 µm) disintegrate in approximately 30–60 seconds at compaction forces of 5–10 kN 7. Increasing the concentration to 2% reduces disintegration time to 20–40 seconds under the same conditions 11. At higher concentrations (≥5%), coarser grades (D50 = 59–86 µm) outperform finer grades: tablets with 5% Croscarmellose Sodium (D50 = 86 µm) disintegrate in 15–25 seconds at 10 kN, compared to 40–60 seconds for D50 = 34 µm 17. This counterintuitive result is attributed to reduced gel layer formation and enhanced elastic recovery in coarser particles 7.
The swelling capacity of Croscarmellose Sodium is also influenced by the ionic strength and pH of the dissolution medium. In deionized water, maximum swelling is observed at neutral pH (6.0–7.5), where carboxymethyl groups are fully ionized and electrostatic repulsion between chains is maximized 16. In acidic media (pH <3.0), protonation of carboxyl groups reduces swelling, while in alkaline media (pH >9.0), excessive ionization may lead to chain extension and gel formation 9. For pharmaceutical applications, Croscarmellose Sodium is typically formulated to function optimally in the physiological pH range (1.0–7.5) encountered in the gastrointestinal tract 1.
Particle size is a critical determinant of Croscarmellose Sodium swelling kinetics and disintegration performance. Fine particle grades (D50 = 5–36 µm, D[4,3] ≤40 µm) offer several advantages:
However, fine particles exhibit limitations at higher concentrations (≥4% w/w) and under high compaction forces (≥10 kN). At these conditions, fine particles form dense, compacted layers that impede water penetration and reduce swelling efficiency 7. Additionally, the increased surface area of fine particles may promote gel layer formation at the particle-water interface, slowing disintegration 7.
Coarser particle grades (D50 ≥56 µm, D90 ≤80 µm) address these limitations by providing:
Experimental data from patent 7 demonstrate that tablets containing 5% Croscarmellose Sodium with D50 = 86 µm disintegrate in 18 seconds at 10 kN, compared to 55 seconds for D50 = 34 µm. At 0.5% concentration, the trend reverses: D50 = 34 µm disintegrates in 35 seconds, while D50 = 86 µm requires 50 seconds 7. These findings underscore the importance of matching particle size to formulation requirements.
In taste-masking applications, particle size of the active pharmaceutical ingredient (API) is equally critical. Croscarmellose Sodium coatings (10–50% w/w of substrate) effectively mask bitter taste when applied to API particles with sizes of 50–500 µm 10. Particles <60 µm exhibit reduced taste-masking efficiency, as the coating thickness relative to particle diameter becomes insufficient to prevent API dissolution in saliva 10. Conversely, particles >500 µm may produce an undesirable gritty mouthfeel 10. Optimal taste masking is achieved with API particles of 125–300 µm coated with 18–25% w/w Croscarmellose Sodium, applied via fluidized bed coating at inlet temperatures below the API melting point 8.
Croscarmellose Sodium is one of three major classes of superdisintegrants, alongside sodium starch glycolate (cross-linked carboxymethyl potato starch) and crospovidone (cross-linked polyvinylpyrrolidone) 1. Each class exhibits distinct swelling mechanisms and performance characteristics:
| Property | Croscarmellose Sodium | Sodium Starch Glycolate | Crospovidone |
|---|---|---|---|
| Primary Mechanism | Wicking + Swelling + Elastic Recovery 1 | Swelling 1 | Swelling 1 |
| Water Solubility | Insoluble 1 | Insoluble 1 | Insoluble 1 |
| Gel Formation | Minimal (fibrous structure) 1 | High at >5% concentration 1 | Minimal 1 |
| Typical Use Level | 0.5–5% (up to 20% for extended release) 1 | 2–8% 1 | 2–5% 1 |
| Swelling Capacity | High (>20% w/w water absorption) 16 | Moderate (gelling limits uptake) 1 | High 1 |
| Compaction Sensitivity | Moderate (optimized by particle size) 7 | High (gelling increases with compression) 1 | Low 1 |
| Fibrous Structure | Yes 1 | No 1 | No 1 |
Croscarmellose Sodium offers superior disintegration at low use levels (≤2%) due to its combined wicking and elastic recovery mechanisms 1. Unlike sodium starch glycolate, which forms viscous gels at concentrations >5%, Croscarmellose Sodium maintains particle integrity even at 10–20% w/w, enabling applications in extended-release formulations where controlled swelling is required 15. Compared to crospovidone, Croscarmellose Sodium provides faster disintegration in low-porosity tablets due to its fibrous structure, which facilitates water penetration 1.
The relationship between particle size, concentration, and compaction force is critical for formulation design. At low concentrations (0.5–2%), fine particles (D50 = 34 µm) outperform coarser grades across all compaction forces (5–15 kN) 7. At moderate concentrations (2–4%), performance is comparable across particle sizes 11. At high concentrations (≥5%), coarser particles (D50 = 59–86 µm) exhibit significantly shorter disintegration times, particularly at compaction forces >10 kN 17. For example, at 5% concentration and 12 kN compaction, D50 = 86 µm disintegrates in 22 seconds versus 58 seconds for D50 = 34 µm 17.
This behavior is explained by the balance between surface area (favoring fine particles) and gel layer formation (favoring coarse particles). At high concentrations and compaction forces, the increased packing density of fine particles creates a barrier to water penetration, while coarser particles maintain interparticulate voids that facilitate wicking 7.
Croscarmellose Sodium is the disintegrant of choice for immediate-release (IR) solid dosage forms requiring rapid drug dissolution. Typical concentrations range from 0.5% to 5% w/w, with fine particle grades (D50 = 5–36 µm) preferred for low-dose form
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| FMC CORPORATION | Immediate-release tablets and capsules requiring rapid disintegration at low disintegrant concentrations, particularly for moisture-sensitive or low-dose formulations. | Ac-Di-Sol® | Fine particle croscarmellose (D50: 5-36 μm) with specific surface area ≥0.3 m²/g accelerates disintegration through combined wicking, swelling, and deformation recovery mechanisms due to fibrous cross-linked structure, providing superior performance at low use levels (≤2%). |
| FMC CORPORATION | High-dose pharmaceutical tablets and compacted solid forms requiring enhanced disintegration performance at elevated compression forces and superdisintegrant concentrations. | Ac-Di-Sol® (Coarse Grade) | Coarse particle croscarmellose (D50: 59-86 μm) reduces disintegration time by 30-50% at high concentrations (≥4% w/w) under compaction forces of 10-15 kN, minimizing gel layer formation while maintaining elastic recovery capacity. |
| R.P. SCHERER TECHNOLOGIES | Orally disintegrating tablets and chewable formulations containing bitter-tasting active pharmaceutical ingredients requiring taste masking without compromising dissolution kinetics. | Taste-Masked Pharmaceutical Compositions | Croscarmellose sodium coating (10-50% w/w of substrate) on API particles (125-300 μm) provides dual functionality as taste-masking agent and superdisintegrant, eliminating need for separate coating and disintegrant agents while maintaining rapid tablet disintegration. |
| SHIONOGI & CO. LTD. | Extended-release oral solid dosage forms requiring controlled swelling and sustained drug release over prolonged periods in the gastrointestinal tract. | Extended Release Formulation | Croscarmellose sodium combined with alkali metal salts (sodium/potassium carbonate) and magnesium oxide or water-soluble polymers controls drug dissolution while maintaining structural integrity under gastrointestinal peristaltic movement, enabling sustained release at 10-20% w/w concentrations. |
| INNATE S.R.L. | Injectable hydrogel applications for viscosupplementation and intradermal filling procedures requiring biocompatible materials with controlled water absorption and swelling characteristics. | Injectable Hydrogel Composition | Micronized croscarmellose sodium in heat-treated (90-150°C) aqueous hydrogel formulation exhibits controlled swelling capacity (absorbing water many times its weight) without BDDE cross-linking, providing biocompatible viscosupplementation properties. |